XML 82 R69.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jun. 30, 2022
Feb. 28, 2022
Dec. 31, 2018
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Mar. 15, 2024
Feb. 28, 2024
Feb. 28, 2023
Mar. 31, 2022
Feb. 28, 2021
Subsidiary or Equity Method Investee [Line Items]                      
Weighted average exercise price of options exercisable       $ 70.60              
Weighted average remaining contractual life of options exercisable       1 year 8 months 2 days              
Aggregate intrinsic value of options exercisable       $ 13,700,000              
Straight line basis over the requisite       3 years              
Dividends payable, amount per share (in dollars per share)   $ 2.00             $ 2.50   $ 1.00
Percentage of increase in annual dividend   100.00%                  
Interparfums SA [Member]                      
Subsidiary or Equity Method Investee [Line Items]                      
Aggregate cost       $ 4,200,000              
Interparfums SA [Member]                      
Subsidiary or Equity Method Investee [Line Items]                      
Aggregate cost       4,100,000              
Board of Directors Chairman [Member]                      
Subsidiary or Equity Method Investee [Line Items]                      
Dividends payable, amount per share (in dollars per share)             $ 0.75 $ 3.00      
Interparfums SA Subsidiary [Member]                      
Subsidiary or Equity Method Investee [Line Items]                      
Shares adjusted for stock splits 211,955                    
Recognized as compensation cost       $ 4,800,000              
Interparfums SA Subsidiary [Member] | Employees [Member]                      
Subsidiary or Equity Method Investee [Line Items]                      
Adjusted for stock splits (in shares)     26,600 87,609           88,400  
Aggregate intrinsic value of options outstanding     133,000                
Number of share distributed       93,405              
Equity Option [Member]                      
Subsidiary or Equity Method Investee [Line Items]                      
Number of shares available for grant (in shares)       537,365              
Aggregate intrinsic value of options outstanding       $ 17,900,000              
Term       5 years              
Stock Option One [Member]                      
Subsidiary or Equity Method Investee [Line Items]                      
Aggregate intrinsic value of options outstanding       $ 2,900,000              
Equity Option [Member]                      
Subsidiary or Equity Method Investee [Line Items]                      
Fair value of shares vested       $ 1,200,000 $ 1,300,000 $ 1,400,000          
Weighted average grant date fair value (in dollars per share)       $ 35.08 $ 20.36 $ 11.35          
Minimum [Member] | Equity Option [Member]                      
Subsidiary or Equity Method Investee [Line Items]                      
Share-based compensation arrangement by share-based payment award, award vesting period       4 years              
Maximum [Member] | Equity Option [Member]                      
Subsidiary or Equity Method Investee [Line Items]                      
Share-based compensation arrangement by share-based payment award, award vesting period       5 years